Corporate Governance

We at BioNTech believe that adhering to the highest Corporate Governance standards positively impacts our performance and we put great importance on building trust with investors, the public and other stakeholders. We are committed to transparency of corporate communication and cooperation between our Management and Supervisory Board aimed at increasing shareholder value over the long term.

Wir glauben, dass sich die Einhaltung der Corporate Governance-Standards positiv auf unsere Performance auswirkt. Wir legen großen Wert darauf, Vertrauen bei Investoren, der Öffentlichkeit und anderen Stakeholdern aufzubauen. BioNTech SE baut auf eine transparente Unternehmenskommunikation und Zusammenarbeit zwischen Vorstand und Aufsichtsrat mit dem Ziel, den Unternehmenswert langfristig zu steigern.

Management Team

Supervisory Board

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

= Chairperson = Member = Financial Expert for Audit Committee

	Audit Committee	Capital Markets Committee	Compensation, Nominating and Corporate Governance Committee
Prof. Christopher Huber	Audit Committee		Compensation, Nominating and Corporate Governance Committee
Helmut Jeggle		Capital Markets Committee
Michael Motschmann	Audit Committee	Capital Markets Committee	Compensation, Nominating and Corporate Governance Committee
Dr. Ulrich Wandschneider	Audit Committee		Compensation, Nominating and Corporate Governance Committee